Mylan and Sanofi both seek summary judgment in EpiPen suit
EpiPen maker Mylan and Sanofi-Aventis, which used to make a competing device, have made opposing bids for summary judgment in Sanofi’s antitrust lawsuit against Mylan.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10